You can read the full article at Efficacy and safety of tirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial In a phase 3 trial conducted in Japan, the efficacy and safety of tirzepatide, a new medication for type 2 diabetes, were compared to dulaglutide
Common side effects include tingling sensations, cognitive changes, and potential birth defects, which limits its use in certain patient populations
Rapid weight loss can temporarily raise uric acid and trigger a flare in the first few months
GHK-Cu is a signalling peptide, not a structural one
As far as the time of day thats best to take a vitamin D supplement, there isnt any research that says morning or night is better
Researchers frequently study this highly stable compound to investigate central melanocortin receptor activation and its downstream physiological effects